Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Mahlert

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Bioconjugate Chemistry|July 16, 2020
Tailored Linker Chemistries for the Efficient and Selective Activation of ADCs with KSPi PayloadsHans-Georg Lerchen, Beatrix Stelte-Ludwig, Anette Sommer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 15, 2019
Antibody-Prodrug Conjugates with KSP Inhibitors and Legumain-Mediated Metabolite FormationHans-Georg Lerchen, Beatrix Stelte-Ludwig, Sandra Berndt, et al.
Angewandte Chemie (International Ed. in English)|September 5, 2018
Antibody-Drug Conjugates with Pyrrole-Based KSP Inhibitors as the Payload ClassHans-Georg Lerchen, Sven Wittrock, Beatrix Stelte-Ludwig, et al.
Cancers|November 25, 2020
IL3RA-Targeting Antibody-Drug Conjugate BAY-943 with a Kinesin Spindle Protein Inhibitor Payload Shows Efficacy in Preclinical Models of Hematologic MalignanciesDennis Kirchhoff, Beatrix Stelte-Ludwig, Hans-Georg Lerchen, et al.
Cancer Research|August 21, 2016
Preclinical Efficacy of the Auristatin-Based Antibody-Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid TumorsAnette Sommer, Charlotte Kopitz, Christoph A Schatz, et al.
Bioconjugate Chemistry|June 6, 2022
A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer TherapyNiels Böhnke, Markus Berger, Nils Griebenow, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Bioconjugate Chemistry|July 16, 2020
Tailored Linker Chemistries for the Efficient and Selective Activation of ADCs with KSPi PayloadsHans-Georg Lerchen, Beatrix Stelte-Ludwig, Anette Sommer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 15, 2019
Antibody-Prodrug Conjugates with KSP Inhibitors and Legumain-Mediated Metabolite FormationHans-Georg Lerchen, Beatrix Stelte-Ludwig, Sandra Berndt, et al.
Angewandte Chemie (International Ed. in English)|September 5, 2018
Antibody-Drug Conjugates with Pyrrole-Based KSP Inhibitors as the Payload ClassHans-Georg Lerchen, Sven Wittrock, Beatrix Stelte-Ludwig, et al.
Cancers|November 25, 2020
IL3RA-Targeting Antibody-Drug Conjugate BAY-943 with a Kinesin Spindle Protein Inhibitor Payload Shows Efficacy in Preclinical Models of Hematologic MalignanciesDennis Kirchhoff, Beatrix Stelte-Ludwig, Hans-Georg Lerchen, et al.
Cancer Research|August 21, 2016
Preclinical Efficacy of the Auristatin-Based Antibody-Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid TumorsAnette Sommer, Charlotte Kopitz, Christoph A Schatz, et al.
Bioconjugate Chemistry|June 6, 2022
A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer TherapyNiels Böhnke, Markus Berger, Nils Griebenow, et al.
Pageof 2